Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters-Reference-Cited by-同舟云学术

Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters

Published:2021 Issue: Volume: Page:
ISSN:
Container-title:Reference Module in Biomedical Sciences
language:
Short-container-title:

Author:

Arbitrio Mariamena,Scionti Francesca,Di Martino Maria Teresa,Pensabene Licia,Tassone Pierfrancesco,Tagliaferri Pierosandro

Publisher

Elsevier

Reference421 articles.

1. Metabolism of bilirubin by human cytochrome P450 2A6;Abu-Bakar;Toxicology and Applied Pharmacology,2012

2. Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro;Adam;Molecular Cancer Research,2003

3. DMET(TM) genotyping: Tools for biomarkers discovery in the era of precision medicine;Agapito;High Throughput,2020

4. Polymorphisms of human N-acetyltransferases and cancer risk;Agundez;Current Drug Metabolism,2008

5. Cyp2d6 genes and risk of liver-cancer;Agundez;Lancet,1995

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vincristine exposure in Kenyan children with cancer: CHAPATI feasibility study;Pediatric Blood & Cancer;2024-07-02

2. The Cytochrome P450 2C8*3 Variant (rs11572080) Is Associated with Improved Asthma Symptom Control in Children and Altered Lipid Mediator Production and Inflammatory Response in Human Bronchial Epithelial Cells;Drug Metabolism and Disposition;2024-05-21

3. Use of the benchmark‐dose (BMD) approach to derive occupational exposure limits (OELs) for genotoxic carcinogens: N‐nitrosamines;Journal of Applied Toxicology;2023-03-09